Report Detail
Global (United States, European Union and China) Inhalation Spray-Based Drugs Market Research Report 2019-2025
- RnM3689238 |
- 22 August, 2019 |
- Global |
- 119 Pages |
- QYResearch |
- Pharma & Healthcare
Inhalation based dosage forms are intended for direct delivery of medicament to lungs to produce local or systematic effects. Inhalation spray-based systems consist of drug formulation (solution, suspension or dry powder) and container-closure system, which do not contain any propellant.
The global market for inhalation spray-based drugs is expected to be driven by increasing incidence of respiratory diseases such as asthma and COPD, need for improved drug delivery mechanisms for quick action, increasing incidence of asthma in children etc.
In 2019, the market size of Inhalation Spray-Based Drugs is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Inhalation Spray-Based Drugs.
This report studies the global market size of Inhalation Spray-Based Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Inhalation Spray-Based Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.
In global market, the following companies are covered:
Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.)
Allergan Plc.
CHIESI Farmaceutici S.p.A
Serenity Pharmaceuticals, LLC
Boehringer Ingelheim GmbH
GlaxoSmithKline plc
Teva Pharmaceuticals
AstraZeneca Plc.
Opko Health
Market Segment by Product Type
Corticosteroids
Bronchodilators
Antihistamines
Combination Drugs
Market Segment by Application
Hospital Pharmacy
Retail Pharmacy
Drug Stores
Clinics
Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)
The study objectives are:
To analyze and research the Inhalation Spray-Based Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Inhalation Spray-Based Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
In this study, the years considered to estimate the market size of Inhalation Spray-Based Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
Table of Contents
1 Report Overview
- 1.1 Study Scope
- 1.2 Major Manufacturers Covered in This Report
- 1.3 Market Segment by Type
- 1.3.1 Global Inhalation Spray-Based Drugs Market Size Growth Rate by Type (2019-2025)
- 1.3.2 Corticosteroids
- 1.3.3 Bronchodilators
- 1.3.4 Antihistamines
- 1.3.5 Combination Drugs
- 1.4 Market Segment by Application
- 1.4.1 Global Inhalation Spray-Based Drugs Market Share by Application (2019-2025)
- 1.4.2 Hospital Pharmacy
- 1.4.3 Retail Pharmacy
- 1.4.4 Drug Stores
- 1.4.5 Clinics
- 1.5 Study Objectives
- 1.6 Years Considered
2 Global Growth Trends
- 2.1 Global Inhalation Spray-Based Drugs Market Size
- 2.1.1 Global Inhalation Spray-Based Drugs Revenue 2014-2025
- 2.1.2 Global Inhalation Spray-Based Drugs Sales 2014-2025
- 2.2 Inhalation Spray-Based Drugs Growth Rate by Regions
- 2.2.1 Global Inhalation Spray-Based Drugs Sales by Regions 2014-2019
- 2.2.2 Global Inhalation Spray-Based Drugs Revenue by Regions 2014-2019
- 2.3 Industry Trends
- 2.3.1 Market Top Trends
- 2.3.2 Market Drivers
3 Market Share by Manufacturers
- 3.1 Inhalation Spray-Based Drugs Sales by Manufacturers
- 3.1.1 Inhalation Spray-Based Drugs Sales by Manufacturers 2014-2019
- 3.1.2 Inhalation Spray-Based Drugs Sales Market Share by Manufacturers 2014-2019
- 3.2 Revenue by Manufacturers
- 3.2.1 Inhalation Spray-Based Drugs Revenue by Manufacturers (2014-2019)
- 3.2.2 Inhalation Spray-Based Drugs Revenue Share by Manufacturers (2014-2019)
- 3.2.3 Global Inhalation Spray-Based Drugs Market Concentration Ratio (CR5 and HHI)
- 3.3 Inhalation Spray-Based Drugs Price by Manufacturers
- 3.4 Key Manufacturers Inhalation Spray-Based Drugs Plants/Factories Distribution and Area Served
- 3.5 Date of Key Manufacturers Enter into Inhalation Spray-Based Drugs Market
- 3.6 Key Manufacturers Inhalation Spray-Based Drugs Product Offered
- 3.7 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
- 4.1 Sales and Revenue for Each Type
- 4.1.1 Corticosteroids Sales and Revenue (2014-2019)
- 4.1.2 Bronchodilators Sales and Revenue (2014-2019)
- 4.1.3 Antihistamines Sales and Revenue (2014-2019)
- 4.1.4 Combination Drugs Sales and Revenue (2014-2019)
- 4.2 Global Inhalation Spray-Based Drugs Sales Market Share by Type
- 4.3 Global Inhalation Spray-Based Drugs Revenue Market Share by Type
- 4.4 Inhalation Spray-Based Drugs Price by Type
5 Market Size by Application
- 5.1 Overview
- 5.2 Global Inhalation Spray-Based Drugs Sales by Application
6 United States
- 6.1 United States Inhalation Spray-Based Drugs Breakdown Data by Company
- 6.2 United States Inhalation Spray-Based Drugs Breakdown Data by Type
- 6.3 United States Inhalation Spray-Based Drugs Breakdown Data by Application
7 European Union
- 7.1 European Union Inhalation Spray-Based Drugs Breakdown Data by Company
- 7.2 European Union Inhalation Spray-Based Drugs Breakdown Data by Type
- 7.3 European Union Inhalation Spray-Based Drugs Breakdown Data by Application
8 China
- 8.1 China Inhalation Spray-Based Drugs Breakdown Data by Company
- 8.2 China Inhalation Spray-Based Drugs Breakdown Data by Type
- 8.3 China Inhalation Spray-Based Drugs Breakdown Data by Application
9 Rest of World
- 9.1 Rest of World Inhalation Spray-Based Drugs Breakdown Data by Company
- 9.2 Rest of World Inhalation Spray-Based Drugs Breakdown Data by Type
- 9.3 Rest of World Inhalation Spray-Based Drugs Breakdown Data by Application
- 9.4 Rest of World Inhalation Spray-Based Drugs Breakdown Data by Countries
- 9.4.1 Rest of World Inhalation Spray-Based Drugs Sales by Countries
- 9.4.2 Rest of World Inhalation Spray-Based Drugs Revenue by Countries
- 9.4.3 Japan
- 9.4.4 Korea
- 9.4.5 India
- 9.4.6 Southeast Asia
10 Company Profiles
- 10.1 Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.)
- 10.1.1 Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.) Company Details
- 10.1.2 Company Description and Business Overview
- 10.1.3 Sales, Revenue and Market Share of Inhalation Spray-Based Drugs
- 10.1.4 Inhalation Spray-Based Drugs Product Introduction
- 10.1.5 Roxane Laboratories Inc. (subsidiary of West-Ward Pharmaceuticals Corp.) Recent Development
- 10.2 Allergan Plc.
- 10.2.1 Allergan Plc. Company Details
- 10.2.2 Company Description and Business Overview
- 10.2.3 Sales, Revenue and Market Share of Inhalation Spray-Based Drugs
- 10.2.4 Inhalation Spray-Based Drugs Product Introduction
- 10.2.5 Allergan Plc. Recent Development
- 10.3 CHIESI Farmaceutici S.p.A
- 10.3.1 CHIESI Farmaceutici S.p.A Company Details
- 10.3.2 Company Description and Business Overview
- 10.3.3 Sales, Revenue and Market Share of Inhalation Spray-Based Drugs
- 10.3.4 Inhalation Spray-Based Drugs Product Introduction
- 10.3.5 CHIESI Farmaceutici S.p.A Recent Development
- 10.4 Serenity Pharmaceuticals, LLC
- 10.4.1 Serenity Pharmaceuticals, LLC Company Details
- 10.4.2 Company Description and Business Overview
- 10.4.3 Sales, Revenue and Market Share of Inhalation Spray-Based Drugs
- 10.4.4 Inhalation Spray-Based Drugs Product Introduction
- 10.4.5 Serenity Pharmaceuticals, LLC Recent Development
- 10.5 Boehringer Ingelheim GmbH
- 10.5.1 Boehringer Ingelheim GmbH Company Details
- 10.5.2 Company Description and Business Overview
- 10.5.3 Sales, Revenue and Market Share of Inhalation Spray-Based Drugs
- 10.5.4 Inhalation Spray-Based Drugs Product Introduction
- 10.5.5 Boehringer Ingelheim GmbH Recent Development
- 10.6 GlaxoSmithKline plc
- 10.6.1 GlaxoSmithKline plc Company Details
- 10.6.2 Company Description and Business Overview
- 10.6.3 Sales, Revenue and Market Share of Inhalation Spray-Based Drugs
- 10.6.4 Inhalation Spray-Based Drugs Product Introduction
- 10.6.5 GlaxoSmithKline plc Recent Development
- 10.7 Teva Pharmaceuticals
- 10.7.1 Teva Pharmaceuticals Company Details
- 10.7.2 Company Description and Business Overview
- 10.7.3 Sales, Revenue and Market Share of Inhalation Spray-Based Drugs
- 10.7.4 Inhalation Spray-Based Drugs Product Introduction
- 10.7.5 Teva Pharmaceuticals Recent Development
- 10.8 AstraZeneca Plc.
- 10.8.1 AstraZeneca Plc. Company Details
- 10.8.2 Company Description and Business Overview
- 10.8.3 Sales, Revenue and Market Share of Inhalation Spray-Based Drugs
- 10.8.4 Inhalation Spray-Based Drugs Product Introduction
- 10.8.5 AstraZeneca Plc. Recent Development
- 10.9 Opko Health
- 10.9.1 Opko Health Company Details
- 10.9.2 Company Description and Business Overview
- 10.9.3 Sales, Revenue and Market Share of Inhalation Spray-Based Drugs
- 10.9.4 Inhalation Spray-Based Drugs Product Introduction
- 10.9.5 Opko Health Recent Development
11 Value Chain and Sales Channels Analysis
- 11.1 Value Chain Analysis
- 11.2 Sales Channels Analysis
- 11.2.1 Inhalation Spray-Based Drugs Sales Channels
- 11.2.2 Inhalation Spray-Based Drugs Distributors
- 11.3 Inhalation Spray-Based Drugs Customers
12 Market Forecast
- 12.1 Global Inhalation Spray-Based Drugs Sales and Revenue Forecast 2019-2025
- 12.2 Global Inhalation Spray-Based Drugs Sales Forecast by Type
- 12.3 Global Inhalation Spray-Based Drugs Sales Forecast by Application
- 12.4 Inhalation Spray-Based Drugs Forecast by Regions
- 12.4.1 Global Inhalation Spray-Based Drugs Sales Forecast by Regions 2019-2025
- 12.4.2 Global Inhalation Spray-Based Drugs Revenue Forecast by Regions 2019-2025
- 12.5 United States Market Forecast
- 12.6 European Union Market Forecast
- 12.7 China Market Forecast
- 12.8 Rest of World
- 12.8.1 Japan
- 12.8.2 Korea
- 12.8.3 India
13 Research Findings and Conclusion
14 Appendix
- 14.1 Research Methodology
- 14.1.1 Methodology/Research Approach
- 14.1.1.1 Research Programs/Design
- 14.1.1.2 Market Size Estimation
- 14.1.1.3 Market Breakdown and Data Triangulation
- 14.1.2 Data Source
- 14.1.2.1 Secondary Sources
- 14.1.2.2 Primary Sources
- 14.1.1 Methodology/Research Approach
- 14.2 Author Details
Summary:
Get latest Market Research Reports on Inhalation Spray-Based Drugs. Industry analysis & Market Report on Inhalation Spray-Based Drugs is a syndicated market report, published as Global (United States, European Union and China) Inhalation Spray-Based Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Inhalation Spray-Based Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
